Diaz Gill Medicina Laboratorial S.A. listed on RansomHouse leak site

• Ransomware group: RansomHouse
• Country: Brazil
• Sector: Healthcare
• Announcement date: December 15, 2025

The Paraguayan-based clinical laboratory Diaz Gill Medicina Laboratorial S.A. has been listed on the leak site of the threat group known as RansomHouse. The announcement, which appeared on the group's platform on December 15, 2025, follows a claimed cyber incident involving the medical institution.

The claims made by RansomHouse

According to the claims made by the RansomHouse group, a cyber incident occurred at Diaz Gill Medicina Laboratorial S.A. on November 26, 2025. The threat actors allege that the company's IT department attempted to conceal the incident from stakeholders or the public. As a result of this alleged attempt to hide the breach, the group has threatened to leak confidential data and various project documents belonging to the organization.

Ransomware leak sites serve as a platform for cybercriminals to exert pressure on their victims. In these scenarios, attackers often use the threat of publicizing stolen information to coerce organizations into paying a ransom. This tactic is a central component of modern cyber extortion campaigns, where the goal is to maximize the leverage held by the attacker through the threat of reputational or legal damage.

Data involved in the alleged breach

The announcement from RansomHouse claims that the group has obtained confidential data and project documents. However, the listing does not provide any detailed information regarding the specific types or the total scope of the leaked data. The listing names no specific data types or categories of information that have been compromised.

When dealing with data exfiltration, the specific nature of the stolen files remains a critical unknown until the data is actually released. In many cases, attackers may target various types of information to increase their leverage, ranging from internal communications to sensitive technical documentation. In this specific instance, the lack of detailed information regarding the volume or the exact content of the files makes it difficult to assess the full extent of the potential exposure.

The organization profile

Diaz Gill Medicina Laboratorial S.A. is a leading private clinical laboratory based in Paraguay. Established in 1992, the organization operates within the field of medical analysis and diagnostic services, providing essential healthcare services to its patient base.

Implications and industry considerations

This incident highlights the significant risk healthcare institutions face regarding the exposure of sensitive data. Given that the RansomHouse group has been active since 2021 with a focus on data exfiltration and extortion, the potential negative impacts on the institution's operational continuity and patient privacy are notable. The group's adoption of double-extortion tactics—where data is both encrypted and stolen—suggests that the pressure on the institution may increase as the threat of a leak persists.

Depending on the actual content of the leaked data, individuals may be at risk of identity theft or targeted phishing attacks. Furthermore, the institution may face legal sanctions under local and international regulations regarding the protection of health data. Healthcare data is particularly sensitive, and its exposure can lead to long-term consequences for both the provider and the patients involved.

To mitigate such risks, organizations in the healthcare sector often implement various defensive measures. These include robust encryption for data at rest and in transit, strict access controls to limit data exposure, and continuous monitoring of network activity to detect unauthorized access. Additionally, maintaining regular, offline backups and conducting regular security audits are common practices used to enhance resilience against ransomware and data exfiltration attempts. The ongoing evolution of threat groups necessitates a proactive approach to cybersecurity to protect both organizational integrity and patient confidentiality.